Crossmark

Cost-effectiveness of tenofovir disoproxil fumarate prophylaxis for perinatal hepatitis B virus prevention in Ethiopia: a decision analytical modeling

Crossref DOI link: https://doi.org/10.1186/s12889-025-22498-6

Published Online: 2025-04-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Negasa, Abdi Gari

Bobo, Firew Tekle

Falta, Desalegn Feleke

Chala, Temesgen Kabeta

Bayou, Negalign Berhanu
License Information

Text and Data Mining valid from 2025-04-07

Version of Record valid from 2025-04-07
More Information

Article History

Received: 1 January 2025

Accepted: 26 March 2025

First Online: 7 April 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below